MyBioGate partners with innovative healthcare and medical companies to help them obtain funding from China, discover market opportunities in China, and form partnership with Chinese companies. We work with innovative companies to identify, advance, and achieve their goals with proper investment and guidance.
Our multi-cultural team in U.S. and overseas works to empower innovators with the right financial, regulatory, and marketing resources. We help innovation succeed beyond national borders.
VP, Strategic Partnerships
Ms. Li is responsible for the MyBioGate online pitch program and business development in the U.S. She helps Chinese investors find and connect with projects of interest and also helps healthcare companies to enter the Chinese.
Miao Guo Smith, MBA
Ms. Miao Guo Smith oversees the MyBioGate web and application development. She provides both English and Chinese platform technical support and is the backbone of our marketing and operation.
Ms. Tian has 9 years of experience in management consulting and industry research. Ms. Tian graduated from Beijing University of Technology with a Bachelor of Engineering and Master of Economics.
Mr. Dai develops and cultivates investor and partner relationships in China, and provides assistance for overseas projects to enter the Chinese market.
Dr. Ginger Ding
Director, Investment Analyst
Dr. Ding serves as Project Manager of the MyBioGate Investment team. She has a 10-year track record in biomedical research. She was an awardee of Susan G. Komen grant in support of her pre-clinical studies.
Dr. Han Yan
Dr. Yan serves as Project Manager of the MyBioGate Investment team. This team searches, filters and conducts technical due diligence for innovative projects for investors and healthcare professionals in China.
Mr.Xu serves as Investment Manager of the Mybiogate Investment team. He helps innovative projects collaborate with Chinese investors including Industry Parks with government background and top healthcare enterprises.
Mrs Xia serves as a medical writer by translating, editing and/or writing most updated biopharma news around the world. She also provides some more insightful articles in the biopharma area.
Miss Shao is a PhD candidate at Baylor College of Medicine. With her unique background, she thoroughly collects outstanding healthcare projects for Chinese investors.